Farther Finance Advisors’s Lantern Pharma LTRN Stock Holding History

Farther Finance Advisors’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.59K	Sell	8,500 -2,475	-23%	-$5.96K	﹤0.01%	4714
2026 Q2	$45.8K	Buy	+10,975	New	+$32.2K	﹤0.01%	3308

Other funds holding LTRN

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Farther Finance Advisors's LTRN Position: Q3 2026 in Review

Farther Finance Advisors reduced its Lantern Pharma (LTRN) stake by 23% in Q3 2026, selling an estimated $5.96K and leaving 8,500 shares worth $8.59K. The position accounts for ﹤0.01% of the portfolio, ranked #4714.

Farther Finance Advisors first reported a position in LTRN in Q2 2026 and has held it in 2 quarters since. The position peaked at $45.8K in Q2 2026. 2 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.

Farther Finance Advisors held 8,500 shares of Lantern Pharma worth $8.59K as of Q3 2026.
Farther Finance Advisors sold 2,475 Lantern Pharma shares in Q3 2026, an estimated $5.96K.
Lantern Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4714 holding.
Farther Finance Advisors first reported a position in Lantern Pharma in Q2 2026 and has held it in 2 quarters since.
Farther Finance Advisors's Lantern Pharma position peaked at $45.8K in Q2 2026.
2 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.